Dr. Johannes Heverhagen, PhD[email protected]Clinical NewsLearn from NSF crisis to avoid 'gadolinium phobia'When the nephrogenic systemic fibrosis (NSF) crisis broke out, very effective countermeasures were drawn up and implemented. In the current debate over the safety of gadolinium-based MRI contrast agents, we must learn three vital lessons from the NSF episode and bear them in mind, Dr. Johannes Heverhagen, PhD, said.March 21, 2016Page 1 of 1Top StoriesRadiation Oncology/TherapyWhy we must celebrate Charles Joslin's remarkable lifeProf. Charles Joslin died on 30 October 2025 at the age of 97. He made a huge contribution to radiation oncology, writes history columnist Dr. Adrian Thomas.MRIMRI safety and radiation-induced cancer risks dominate in 2025Organized Radiology IssuesWho's bidding for glory at the ESR's 2026 election?Digital X-RayIs imaging always needed for recurring shoulder dislocations?Medical, Legal, and PracticeTake charge of work patterns and look after each other